Vytalize Health is a leading value-based care platform aimed at accelerating the transition to value-based care for patients by supporting the physicians who care for them. The company, established in 2014 and headquartered in the United States, focuses on helping independent physicians and practices thrive in the evolving healthcare landscape by fostering patient relationships through data-driven, holistic, and personalized care. Their comprehensive solution encompasses value-based incentives, cutting-edge technology, and a virtual clinic, empowering independent practices to excel in value-based care arrangements.
Notably, in their latest funding round in February 22, 2023, Vytalize Health secured a significant $100.00M Series C investment from prominent investors including North Coast Ventures, Monroe Capital, and Enhanced Healthcare Partners. The company's impactful care delivery model has already enhanced the healthcare experience for over 250,000+ Medicare beneficiaries spanning 36 states, aiding them in managing chronic conditions in collaboration with their healthcare providers.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | $100.00M | 3 | 22 Feb 2023 | |
Series B | $47.00M | 4 | KittyHawk | 11 Apr 2022 |
Debt Financing | $6.00M | - | 11 Apr 2022 | |
Series A | $17.00M | 1 | KittyHawk | 21 Jan 2021 |
Seed Round | $5.50M | 7 | KittyHawk, Highnote Foundry +2 | 17 Jan 2020 |
No recent news or press coverage available for Vytalize Health.